ESR1 and melanoma: Sarti and coworkers reported that 17β-estradiol exerts a significant inhibitory activity on the proliferation of the human SK-Mel 23 melanoma cell line, expressing ERβ, but not ERα (referred to as “type II estrogen binding site” by these authors) (121).